Authors: Balfour, HH Edelman, CK Anderson, RS Reed, NV Slivken, RM Marmor, LH Dix, L Aeppli, D Talarico, CL

Citation: Hh. Balfour et al., Controlled trial of acyclovir for chickenpox evaluating time of initiationand duration of therapy and viral resistance, PEDIAT INF, 20(10), 2001, pp. 919-926

Authors: Oram, RJ Marcellino, D Strauss, D Gustafson, E Talarico, CL Root, AK Sharma, PL Thompson, K Fingeroth, JD Crumpacker, C Herold, BC

Citation: Rj. Oram et al., Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate, J INFEC DIS, 181(4), 2000, pp. 1458-1461

Authors: Talarico, CL Burnette, TC Miller, WH Smith, SL Davis, MG Stanat, SC Ng, TI He, ZW Coen, DM Roizman, B Biron, KK

Citation: Cl. Talarico et al., Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein, ANTIM AG CH, 43(8), 1999, pp. 1941-1946

Authors: Westphal, EM Mauser, A Swenson, J Davis, MG Talarico, CL Kenney, SC

Citation: Em. Westphal et al., Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo, CANCER RES, 59(7), 1999, pp. 1485-1491